Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Focused Cryo
AddedMar 20, 2024
UpdatedJun 18, 2026
Focused Cryo

Focused Cryo

Seed

Innovative healthcare company in Kennesaw, GA, developing smart cryoablation system for improved treatment.

HQ
Kennesaw, GA, US
Founded
2019
Overview
Compare
Fundraising
Employees

Focused Cryo is a healthcare company that develops a smart cryoablation system that provides better spatiotemporal control.

These benefits represent a significant improvement in the treatment of Type 2 diabetes, obesity, and other ailments that are addressed with the cryoablation of nerves and ganglia. The company is based in Kennesaw, Georgia.

Focused Cryo - Similar Companies

CryoMedix logo

CryoMedix

cryomedix.com

Cryothermic Systems logo

Cryothermic Systems

Gulf States Cryotherapy logo

Gulf States Cryotherapy

Cryosa logo

Cryosa

cryosa.com

Kubanda Cryotherapy logo

Kubanda Cryotherapy

Corfigo logo

Corfigo

corfigo.com

Adagio Medical logo

Adagio Medical

CardioFocus logo

CardioFocus

cardiofocus.com

CoolTech logo

CoolTech

cooltechcorp.com

Cryoex logo

Cryoex

CSA Medical logo

CSA Medical

rejuvenair.com

Controlled Delivery Systems logo

Controlled Delivery Systems

Corveus Medical logo

Corveus Medical

corveusmedical.com

Niche Biomedical logo

Niche Biomedical

MediCool Technologies logo

MediCool Technologies

medicooltech.com

Focused Cryo - Quick Facts

Who are Focused Cryo's competitors?

Companies similar to Focused Cryo include CryoMedix, Cryothermic Systems, Gulf States Cryotherapy and Cryosa.

When was Focused Cryo founded?

Focused Cryo was founded in 2019.

Where is Focused Cryo's headquarters located?

Focused Cryo's headquarters is located in Kennesaw, GA, US.

When was Focused Cryo's last funding round?

Focused Cryo's most recent funding round was for $2.6M (USD) in October 2022.

How much has Focused Cryo raised to-date?

As of Oct 31, 2022, Focused Cryo has raised a total of $6M (USD).

How many employees does Focused Cryo have?

Focused Cryo has 50 employees as of Feb 5, 2024.

Focused Cryo - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cryoablation
  • Medical Devices
Tags
  • Consulting
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified